T1	Participants 32 71	patients after a myocardial infarction:
T2	Participants 270 278	first MI
T3	Participants 284 306	recurrent MI patients.
T4	Participants 550 630	cohort of patients enrolled in the Beta-Blocker in Heart Attack Trial (n = 2830)
T5	Participants 678 713	in-hospital and post-hospital data)